Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03107988
Title NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors New Approaches to Neuroblastoma Therapy Consortium
Age Groups: child | adult | senior
Covered Countries USA | GBR | FRA | CAN

Additional content available in CKB BOOST